Radyalis Releases Next-Generation Monte Carlo Proton Therapy Planning

July 22, 2014 — Radyalis is showcasing its high-performance Monte Carlo dose calculation product for proton applications simultaneously at the 2014 annual meeting of the American Association of Physics in Medicine (AAPM) in Austin, Texas.

The company’s work in large-scale optimization and high-performance computing enables clinicians to utilize the high-accuracy benefits of Monte Carlo at unprecedented speeds for proton therapy dose modeling. The Monte Carlo engine changes radiotherapy workflow as the most complex patient treatment plans can be evaluated for efficacy and biological safety with high confidence in a matter of minutes.

The technology combines new algorithmic and software architecture advances for very high parallel efficiency on customer's existing hardware, including single and multiple node installations, clusters and cloud platforms, for both Linux and Windows environments. Radyalis software is highly portable and very flexible, and designed to be integrated via a customer API or into a treatment planner.

Without compromise, Monte Carlo supports a robust set of features. All relevant physics are accurately modeled. Simulation of complex geometries, NIST materials and multiple beams are fully supported. Radyalis provides sophisticated dosage statistics including particle distributions, variability, fluence and linear energy transfer, further guiding the radiation physicist.

The fast and accurate Monte Carlo dose calculator is a key enabler for next-generation treatment plan optimization, robust planning, quality assurance and ultimately real-time adaptive planning. The speed and accuracy of Radyalis' Monte Carlo product provides significant ROI advantages for equipment manufacturers, treatment centers and research organizations.

For more information: www.radyalis.com


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now